Skip to main content

A ray of hope for arthritis




​Thanks to ancient science Ayurveda which came up with a unique wonder drug under the name of S.Compound.

Work on herb was started in the year 1974 and ultimately it was confirmed that the herb has great potential in inflammatory conditions. However, its role on arthritis was explored because it was the most neglected disease by the scientists and Medical fraternity. The available pain killers were causing huge harm to our body systems and some of the available pain killers were even banned in Europe.
The herbal medicine S.Compound was compared with Phenylbutazone by the scientists of Central Drug Research Institute Lucknow in the year 1983 and was found better in efficacy

Controlled Clinical trials were carried out on human beings suffering from Rheumatoid arthritis; Is not only its efficacy was confirmed but it was also found safe in long duration. The research work was published in Eastern Pharmacist which was reported by country's premier News Agency United News of India on 21.06.1982 0under the caption: Hope for arthritis patients. 

The news states Jammu Pharmaceutical firm has developed an Ayurvedic Medicine that may prove a ray of hope for arthritis patients. It was observed during trials conducted in patients suffering from chronic Rheumatoid arthritis that the drug afforded between 70 and 80 percent relief with regard to swelling in joints and tenderness, morning stiffness, walking time and patients own impression of overall disease activity. According to Eastern Pharmacist, a leading pharmaceutical journal, it appears that the drug acts on the basic pathological process responsible for the genesis of Rheumatoid arthritis.

Due to coverage in large number of Indian News Papers, Indian Health Minister gave. A statement in November 1983 that Rahul Pharma Jammu developed an Ayurvedic drug in the name of S.Compound .The main ingredient of the drug is Salai sGuggul. This drug is claimed to be very effective for the treatment of Rheumatoid arthritis.

Former Union Minister of State for Commerce Shantilal Patel while speaking to Indian Express on 29.05.2004 stated that Arthritis is one of the most painful diseases and has increased many folds due to change in life style of people, he said,based on his experiences, that the persons who live a sedentary life are the most affected people.

Continue reading​

Comments

Post a Comment

Popular posts from this blog

Registration of herbal trials in CTRI is not mandatory

A trial patient visited the site complaining breathlessness and tachycardia. The investigator advised hospitalization but as subject could not afford the expenses, he refused for admission. Is this an SAE because investigator advised hospitalization? G Praveen Kumar. If the patient was not hospitalized, it does not fall into SAE criteria of hospitalization. However, it appears from your mail that the PI felt that the event was serious enough to admit the subject for treatment. This makes it an “important medical event." As per ICH E2A such event also are considered serious. See the ICH E2A excerpt below: Medical and scientific judgement should be exercised in deciding whether expedited reporting is appropriate in other situations, such as important medical events that may not be immediately life-threatening or result in death or hospitalisation but may jeopardise the patient or may require intervention to prevent one of the other outcomes listed in the defin...
Post a Comment
Read more

Evidence for Atypical Antipsychotic Drugs Called into Question

Despite massive advertising and booming prescriptions, use and sales, the new atypical antipsychotic medications such as Seroquel and Abilify – used to treat schizophrenia , bipolar disorder, depression and other illnesses – lack sufficient evidence to support their widespread and generalized usage. This according to a new study out of the Stanford University School of Medicine and University of Chicago. In the past decade, atypical antipsychotics have rocketed past many commonly prescribed, but older antidepressant and other psychiatric medications. Although initially touted as having few side effects, followup studies have found that atypical antipsychotics have serious side effects, including significant weight gain that can lead to diabetes and heart disease. “Because these drugs have safety issues, physicians should prescribe them only when they are sure patients will get substantial benefits,” said Randall Stafford, M.D., Ph.D., a Stanford associate pro...
Post a Comment
Read more

In India, there is no separate guidance on pregnancy reporting

How will we conclude that the subject is illiterate? Dr Prakash Atlam The guidelines don’t use the term illiterate. Their focus is subject’s ability to read and/or write. Schedule Y treats anyone who is unable to read or write in the same way. See the excerpt below. If the subject or his/her legally acceptable representative is unable to read/write - an impartial witness should be present during the entire informed consent process who must append his/her signatures to the consent form. While designing a protocol we found that there are high likely chances of worsening of some of the symptoms. Do we have to wait for these to happen and report it as SAE or in case we define them in the protocol upfront then can we prevent from expediting reporting it as SAE? Om Please see suggested guidance from ICH. Exemption from reporting such events would require prior agreement with regulatory authorities. ICH E3 12.2.2 Display of Adverse Events: All adverse events occurrin...
Post a Comment
Read more